Iran on Thursday inaugurated the country’s largest wound treatment clinic in Isfahan, with Vice President and Head of the Atomic Energy Organization of Iran Mohammad Eslami attending the opening ceremony.
Speaking at the inauguration ceremony, Mohammad Eslami said the newly launched facility is the 12th plasma therapy center in Iran, describing it as a unique medical complex with a nationwide mission.
He noted that the center provides both outpatient services and inpatient care, offering comprehensive treatment for patients suffering from post-surgical wound infections.
According to Eslami, the clinic serves as a national hub with wide population coverage and is equipped with the latest and most advanced medical technologies. Patients requiring hospitalization can undergo multiple treatment sessions under the supervision of specialized physicians and medical staff until full recovery is achieved.
Highlighting the effectiveness of plasma therapy in Iran, the head of the Atomic Energy Organization said that more than 2,500 patients have been successfully treated at plasma therapy centers across the country over the past two years.
Eslami also pointed to significant investments made to expand plasma therapy infrastructure nationwide, expressing hope that the development of such facilities will allow more people to benefit from advanced, technology-based medical services, Mehr reported.
Emphasizing the pioneering role of the Atomic Energy Organization of Iran in innovative medical treatments, he said the organization is currently at the forefront of modern therapies in the fields of radiopharmaceuticals and plasma medicine.
He added that the Islamic Republic of Iran has reached parity with, and in some areas surpassed, advanced countries in the production of radiopharmaceuticals—an achievement he described as a source of national pride.
In his concluding remarks, Eslami stressed that the integration of radiopharmaceuticals with modern therapeutic technologies has opened a new chapter in Iran’s healthcare sector, noting that greater efforts in awareness-building and education among both medical professionals and the public would yield more sustainable and effective outcomes, particularly for cancer patients.
